Induction of cytolytic and antibody responses using Plasmodium falciparum repeatless circumsporozoite protein encapsulated in liposomes

K White, U Krzych, DM Gordon, TG Porter, RL Richards… - Vaccine, 1993 - Elsevier
Plasmodium circumsporozoite (CS) protein-induced antibody and T-cell responses are
considered to be important in protective immunity. Since the key repeat determinant of the …

Safety, Immunogenicity, and Efficacy of Plasmodium falciparum Repeatless Circumsporozoite Protein Vaccine Encapsulated in Liposomes

DG Heppner, DM Gordon, M Gross… - Journal of Infectious …, 1996 - academic.oup.com
Seventeen malaria-naive volunteers received a recombinant Plasmodium falciparum
vaccine (RLF) containing the carboxy-and the amino-terminal of the circumsporozoite …

Induction of cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein by immunization with soluble recombinant protein without adjuvant

A Malik, M Gross, T Ulrich, SL Hoffman - Infection and immunity, 1993 - Am Soc Microbiol
Immunization of mice with irradiated malaria sporozoites induces protection that is
dependent on CD8+ T cells, and adoptive transfer of CD8+ cytotoxic T lymphocyte (CTL) …

Liposomes containing lipid A: a potent nontoxic adjuvant for a human malaria sporozoite vaccine

CR Alving, RL Richards - Immunology letters, 1990 - Elsevier
Liposomes containing lipid A have been developed as adjuvants for inducing humoral
immunity to synthetic antigens containing repeat sequence epitopes from the …

Liposomes, lipid A, and aluminum hydroxide enhance the immune response to a synthetic malaria sporozoite antigen

RL Richards, MD Hayre, WT Hockmeyer… - Infection and …, 1988 - Am Soc Microbiol
A liposome-encapsulated cloned protein (R32tet32) containing sequences from the
tetrapeptide repeat region of the circumsporozoite protein of Plasmodium falciparum …

Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy.

LF Fries, DM Gordon, RL Richards… - Proceedings of the …, 1992 - National Acad Sciences
This study describes the safety and immunogenicity of a liposome-based vaccine injected
into human subjects. Thirty healthy adult male volunteers were immunized with a liposome …

A conserved peptide sequence of the Plasmodium falciparum circumsporozoite protein and antipeptide antibodies inhibit Plasmodium berghei sporozoite invasion of …

S Chatterjee, M Wery, P Sharma… - Infection and …, 1995 - Am Soc Microbiol
Minutes after injection into the circulation, malaria sporozoites enter hepatocytes. The speed
and specificity of the invasion process suggest that it is receptor mediated. The region II …

Vaccine co-display of CSP and Pfs230 on liposomes targeting two Plasmodium falciparum differentiation stages

WC Huang, MT Mabrouk, L Zhou, M Baba… - Communications …, 2022 - nature.com
A vaccine targeting multiple stages of the Plasmodium falciparum parasite life cycle is
desirable. The sporozoite surface Circumsporozoite Protein (CSP) is the target of leading …

The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity

SE Bongfen, PM Ntsama, S Offner, T Smith, I Felger… - Vaccine, 2009 - Elsevier
The N-terminal domain of the circumsporozoite protein (CSP) has been largely neglected in
the search for a malaria vaccine in spite of being a target of inhibitory antibodies and …

A Linear Peptide Containing Minimal T- and B-Cell Epitopes of Plasmodium falciparum Circumsporozoite Protein Elicits Protection against Transgenic Sporozoite …

JM Calvo-Calle, GA Oliveira, CO Watta… - Infection and …, 2006 - Am Soc Microbiol
An effective malaria vaccine is needed to address the public health tragedy resulting from
the high levels of morbidity and mortality caused by Plasmodium parasites. The first …